ERalpha as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells
about
BRCA1 and estrogen/estrogen receptor in breast cancer: where they interact?Integration of molecular profiling and chemical imaging to elucidate fibroblast-microenvironment impact on cancer cell phenotype and endocrine resistance in breast cancer14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiationDisseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.Unliganded estrogen receptor alpha promotes PC12 survival during serum starvation.During hormone depletion or tamoxifen treatment of breast cancer cells the estrogen receptor apoprotein supports cell cycling through the retinoic acid receptor α1 apoprotein.Short-Form Ron Promotes Spontaneous Breast Cancer Metastasis through Interaction with Phosphoinositide 3-Kinase.Epigenetic regulation of Kiss1 gene expression mediating estrogen-positive feedback action in the mouse brain.Luminal long non-coding RNAs regulated by estrogen receptor alpha in a ligand-independent manner show functional roles in breast cancerInherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells.Genome-wide activity of unliganded estrogen receptor-α in breast cancer cells.Dissecting the genomic activity of a transcriptional regulator by the integrative analysis of omics data.Differential recruitment of co-regulatory proteins to the human estrogen receptor 1 in response to xenoestrogens.Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma.
P2860
Q26822737-868E444E-FF1F-4E60-A9DB-CA6CE78CDEFCQ28538685-5ACA223C-861B-4D5A-9477-5BF7DD3A0DB1Q33951080-98769A22-7B02-47CE-ACF5-949EB5157C16Q34485079-4C910DC7-F422-4004-B854-516C052922FEQ34795271-2FD17CD0-E0D9-4E38-8A10-D5F7CB961C5DQ35029586-8A14AACE-5ABC-4870-A849-74B4EE36C7FBQ35556501-58F5CDDB-9B16-4A20-94B1-29B4396FEA92Q35974198-9908D510-8FA5-45EA-AE5A-232F2DD16896Q36772092-B428B65B-D69F-4F39-B3BE-0478E0DCECF0Q36778032-974324C2-8720-4B0B-ACE1-315047742E5BQ37013935-FCCD01B2-65D1-44DE-85DC-4445D32AA836Q37687555-53BB352D-828B-4ED0-A894-D45301DDB153Q38429686-125C8612-4D5C-47DD-834F-38222502AAC6Q41739874-258C6E17-4E3A-4B34-9AAC-513BE0DAE900Q43559664-357FB411-5E72-4A88-9E9B-5112896940D4
P2860
ERalpha as ligand-independent activator of CDH-1 regulates determination and maintenance of epithelial morphology in breast cancer cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
ERalpha as ligand-independent ...... phology in breast cancer cells
@en
ERalpha as ligand-independent ...... hology in breast cancer cells.
@nl
type
label
ERalpha as ligand-independent ...... phology in breast cancer cells
@en
ERalpha as ligand-independent ...... hology in breast cancer cells.
@nl
prefLabel
ERalpha as ligand-independent ...... phology in breast cancer cells
@en
ERalpha as ligand-independent ...... hology in breast cancer cells.
@nl
P2093
P2860
P356
P1476
ERalpha as ligand-independent ...... phology in breast cancer cells
@en
P2093
Arantxa Gutierrez
Chiara Bardella
Luciano Di Croce
Maria Dafne Cardamone
Michael G Rosenfeld
Michele De Bortoli
P2860
P304
P356
10.1073/PNAS.0903033106
P407
P577
2009-04-21T00:00:00Z